LONDON - Amersham plc, the UK's largest life sciences company, agreed to be taken over by General Electric Co. in a £5.7 billion (US$9.5 billion) deal that would create a $13 billion turnover business with a vision to drive the development of personalized medicine. (BioWorld International)
LONDON - Amersham plc, the UK's largest life sciences company, agreed to be taken over by General Electric Co. in a £5.7 billion (US$9.5 billion) deal that would create a $13 billion turnover business with a vision to drive the development of personalized medicine. (BioWorld Today)
LONDON - Amersham plc, the UK's largest life sciences company, agreed to be taken over by General Electric Co. in a £5.7 billion (US$9.5 billion) deal that would create a $13 billion turnover business with a vision to drive the development of personalized medicine. (BioWorld Today)
LONDON - Arrow Therapeutics Ltd. raised more than £21 million in the first close of its second-round funding, which should enable it to advance two antiviral products into clinical trials next year and complete preclinical development of antibacterial leads. (BioWorld International)
LONDON - Arrow Therapeutics Ltd. raised more than £21 million in the first close of its second-round funding, which should enable it to advance two antiviral products into clinical trials next year and complete preclinical development of antibacterial leads. (BioWorld International)
